Literature DB >> 21970737

An access to the β-anomer of 4'-thio-C-ribonucleosides: hydroboration of 1-C-aryl- or 1-C-heteroaryl-4-thiofuranoid glycals and its regiochemical outcome.

Kazuhiro Haraguchi1, Chikafumi Horii, Yuichi Yoshimura, Fumiko Ariga, Aya Tadokoro, Hiromichi Tanaka.   

Abstract

We have developed a novel method for the synthesis of the β-anomer of 4'-thio-C-ribonucleosides from 3,5-O-(di-tert-butylsilylene)-4-thiofuranoid glycal. Palladium-catalyzed coupling of 1-tributylstannyl-4-thiofuranoid glycal with iodobenzene or a heteroaryl halide gave 1-C-phenyl- or 1-C-heteroaryl-glycals. Hydroboration of these glycals proceeded at the α-face, and subsequent alkaline hydrogen peroxide treatment of the resulting 2'-α-borane furnished the respective β-anomer of 4'-thio-C-ribonucleosides. These results demonstrate that this synthetic method has a wider scope in terms of heterocyclic base structure. During this study, unexpected Markovnikov-oriented hydroboration has been observed to lead to the respective 1'-α-boranes. These 1'-boranes were converted into either the ring-opened structure or the 2'-deoxy derivatives depending upon their stability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21970737     DOI: 10.1021/jo201100n

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Novel water-soluble substituted pyrrolo[3,2-d]pyrimidines: design, synthesis, and biological evaluation as antitubulin antitumor agents.

Authors:  Aleem Gangjee; Roheeth K Pavana; Wei Li; Ernest Hamel; Cara Westbrook; Susan L Mooberry
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

2.  Novel Substituted Purine Isosteres: Synthesis, Structure-Activity Relationships and Cytotoxic Activity Evaluation.

Authors:  Spyridon Dimitrakis; Efthymios-Spyridon Gavriil; Athanasios Pousias; Nikolaos Lougiakis; Panagiotis Marakos; Nicole Pouli; Katerina Gioti; Roxane Tenta
Journal:  Molecules       Date:  2021-12-31       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.